Gottlieb, who led the agency during the first Trump presidency, supports a reversion to an earlier interpretation of the 21st Century Cures Act.

Before taking his role at the FDA Gottlieb published a long list of pharma and biotech companies that he had worked with, and had to recuse himself from his role as a board member for medical ...

During the transition period, Lykos will work with a number of shareholders to secure financing for an additional Phase III trial of midomafetamine capsules for post-traumatic stress disorder. Lykos ...